| scholarly article | Q13442814 |
| P50 | author | John T. Brooks | Q93069508 |
| P2093 | author name string | Kate Buchacz | |
| Pragna Patel | |||
| Richard M Novak | |||
| Joan S Chmiel | |||
| Carl Armon | |||
| Kathy Wood | |||
| P2860 | cites work | Immunodeficiency as a risk factor for non-AIDS-defining malignancies in HIV-1-infected patients receiving combination antiretroviral therapy. | Q51563023 |
| Cancer survival in patients with HIV/AIDS in the era of highly active antiretroviral therapy in Taiwan: a population-based cohort study. | Q51872230 | ||
| Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. | Q53608173 | ||
| Incidence of Malignancies in HIV‐Infected Patients and Prognostic Role of Current CD4 Cell Count: Evidence from a Large Italian Cohort Study | Q56335318 | ||
| Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study | Q56837790 | ||
| Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies | Q57877211 | ||
| Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003 | Q64126680 | ||
| A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survival | Q73351144 | ||
| Cancer risk among participants in the women's interagency HIV study | Q80249355 | ||
| Mortality and morbidity of HIV infected patients receiving HAART: a cohort study | Q81260158 | ||
| Increased incidence of hepatocellular carcinoma (HCC) in HIV-1 infected patients | Q81655968 | ||
| Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies | Q24597052 | ||
| Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators | Q29547281 | ||
| Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals | Q30482915 | ||
| Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras | Q30482995 | ||
| The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals | Q33505475 | ||
| Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. Adult/Adolescent Spectrum of Disease Group | Q33745869 | ||
| HIV infection and the risk of cancers with and without a known infectious cause | Q33827510 | ||
| Natural history of HIV infection in the era of combination antiretroviral therapy | Q33876280 | ||
| Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion | Q33888845 | ||
| Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy | Q33952616 | ||
| Decline in the AIDS and death rates in the EuroSIDA study: an observational study | Q33967061 | ||
| Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators. | Q34067875 | ||
| Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy | Q34403321 | ||
| Sexual transmission and the natural history of human herpesvirus 8 infection | Q34462040 | ||
| A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals | Q34612071 | ||
| Predictors of survival after a diagnosis of non-Hodgkin lymphoma in a resource-limited setting: a retrospective study on the impact of HIV infection and its treatment | Q34726756 | ||
| Changes in the risk of death after HIV seroconversion compared with mortality in the general population | Q34791057 | ||
| HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies | Q34844389 | ||
| Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy | Q35233148 | ||
| Hepatitis viruses and human immunodeficiency virus co-infection: pathogenesis and treatment | Q35832468 | ||
| Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study | Q36247045 | ||
| Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals | Q36908566 | ||
| Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy | Q37085001 | ||
| High cancer-related mortality in an urban, predominantly African-American, HIV-infected population | Q37288434 | ||
| Evolving epidemiology of malignancies in HIV. | Q37357751 | ||
| Cancer incidence in women with or at risk for HIV. | Q39587834 | ||
| Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women | Q41609539 | ||
| Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4+ counts greater than 200 cells/mm3. | Q44203105 | ||
| Cancer risk in people infected with human immunodeficiency virus in the United States | Q45395561 | ||
| Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma | Q46473122 | ||
| Changes in cancer mortality among HIV-infected patients: the Mortalité 2005 Survey | Q46542543 | ||
| All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration | Q47918470 | ||
| P433 | issue | 1 | |
| P921 | main subject | cancer diagnosis | Q110324059 |
| anti-retroviral agent | Q50430310 | ||
| P304 | page(s) | ofu012 | |
| P577 | publication date | 2014-03-01 | |
| P1433 | published in | Open Forum Infectious Diseases | Q27725953 |
| P1476 | title | Factors associated with cancer incidence and with all-cause mortality after cancer diagnosis among human immunodeficiency virus-infected persons during the combination antiretroviral therapy era. | |
| P478 | volume | 1 |
| Q90122871 | A comparison of cancer stage at diagnosis and treatment initiation between enrollees in an urban HIV clinic and SEER |
| Q93146968 | Cancer in the HIV/AIDS Population in Iowa, 1991-2015 |
| Q36459660 | Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study |
| Q34679292 | Evolving epidemiology of HIV-associated malignancies |
| Q31127155 | High-density lipoprotein-cholesterol levels and risk of cancer in HIV-infected subjects: Data from the ICONA Foundation Cohort |
| Q36931801 | History of AIDS in HIV-Infected Patients Is Associated With Higher In-Hospital Mortality Following Admission for Acute Myocardial Infarction and Stroke |
| Q38629654 | Maintaining lung health with longstanding HIV. |
| Q54211929 | Survival after cancer diagnosis in a cohort of HIV-positive individuals in Latin America. |
| Q34513248 | Testing for human immunodeficiency virus among cancer survivors under age 65 in the United States |
| Q37047999 | Time trends in cancer incidence in persons living with HIV/AIDS in the antiretroviral therapy era: 1997-2012. |
Search more.